Thrombophilia due to thrombin defect: genes and variants
Explore variant evidence for Thrombophilia due to thrombin defect across 4 analyzed proteins (MTHFR, F2, F5, F13A1). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 48 variants of uncertain significance and 38 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Thrombophilia due to thrombin defect
MTHFR: Methylenetetrahydrofolate reductase (NADPH)
It generates 5-methyltetrahydrofolate for remethylation of homocysteine to methionine, linking folate metabolism with methyl-group supply. Severe biallelic deficiency causes homocystinuria with neurologic and thrombotic complications, while common variants produce much smaller effects on homocysteine.
6 ClinVar pathogenic / likely pathogenic and 13 uncertain variants in MTHFR have source records linked to Thrombophilia due to thrombin defect. Association strength is not clinical gene validity.
F2: Prothrombin
After cleavage to thrombin, it converts fibrinogen to fibrin and activates multiple additional coagulation components to amplify clot formation. Deficiency can cause bleeding, whereas the common G20210A variant raises prothrombin levels and increases venous-thrombosis risk.
3 ClinVar pathogenic / likely pathogenic and 12 uncertain variants in F2 have source records linked to Thrombophilia due to thrombin defect. Association strength is not clinical gene validity.
F5: Coagulation factor V
After activation, it serves as an essential cofactor for factor Xa in the prothrombinase complex and greatly accelerates thrombin generation. Deficiency can cause bleeding, whereas factor V Leiden produces activated-protein-C resistance and substantially increases venous-thrombosis risk.
0 ClinVar pathogenic / likely pathogenic and 55 uncertain variants in F5 have source records linked to Thrombophilia due to thrombin defect. Association strength is not clinical gene validity.
F13A1: Coagulation factor XIII A chain
After thrombin activation, it crosslinks fibrin strands and other proteins to stabilize the newly formed blood clot. Biallelic deficiency causes severe bleeding with poor wound healing and a characteristic risk of delayed bleeding and intracranial hemorrhage.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in F13A1 have source records linked to Thrombophilia due to thrombin defect. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Thrombophilia due to thrombin defect
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| MTHFR L323P | 323 | Pathogenic / likely pathogenic (★★) | |
| MTHFR R157Q | 157 | Pathogenic / likely pathogenic (★★) | |
| F2 R596Q | 596 | Peptidase S1 | Pathogenic / likely pathogenic (★★) |
| MTHFR R68G | 68 | Pathogenic / likely pathogenic (★★) | |
| MTHFR I153M | 153 | Pathogenic / likely pathogenic (★★) | |
| MTHFR R183Q | 183 | Pathogenic / likely pathogenic (★★) | |
| MTHFR C243G | 243 | Pathogenic / likely pathogenic (★) | |
| F2 R314C | 314 | Pathogenic / likely pathogenic (★) | |
| F2 R596L | 596 | Peptidase S1 | Pathogenic / likely pathogenic |
Which prediction tools work for Thrombophilia due to thrombin defect
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- REVEL: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 95 out of 100
- ESM1b (LLR): 93 out of 100
- AlphaMissense: 93 out of 100
- MutPred: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 89 out of 100
- MetaSVM: 85 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 84 out of 100
- MetaLR: 82 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SpliceAI: 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 53 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Homocystinuria due to methylene tetrahydrofolate reductase deficiency also has ClinVar records linked to MTHFR variants; they fall mostly in different places as the Thrombophilia due to thrombin defect variants (43 pathogenic / likely pathogenic).
- Neural tube defects, folate-sensitive also has ClinVar records linked to MTHFR variants; they fall mostly in different places as the Thrombophilia due to thrombin defect variants (19 pathogenic / likely pathogenic).
- Prothrombin deficiency also has ClinVar records linked to F2 variants; they fall mostly in different places as the Thrombophilia due to thrombin defect variants (17 pathogenic / likely pathogenic).
Diseases related to Thrombophilia due to thrombin defect
- Ischemic stroke, also linked to F2 and F5
- Homocystinuria due to methylene tetrahydrofolate reductase deficiency, also linked to MTHFR
- Neural tube defects, folate-sensitive, also linked to MTHFR
- Prothrombin deficiency, also linked to F2
- Factor V deficiency, also linked to F5
- Factor XIII, A subunit, deficiency of, also linked to F13A1
- Heart disease, also linked to F2
- Protein c deficiency, also linked to F2
- Schizophrenia, also linked to MTHFR
- Factor XIII deficiency, also linked to F13A1
- Thrombophilia due to activated protein C resistance, also linked to F5
Frequently asked questions
Which genes have records linked to Thrombophilia due to thrombin defect?
This view contains 4 analyzed proteins: MTHFR, F2, F5, F13A1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 48 variants of uncertain significance and 38 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 127 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center